Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.
Identifieur interne : 000545 ( PubMed/Curation ); précédent : 000544; suivant : 000546Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.
Auteurs : T. Bach [Allemagne] ; G. Wendt-Nordahl ; M S Michel ; T R W. Herrmann ; A J GrossSource :
- World journal of urology [ 1433-8726 ] ; 2009.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Humains, Hyperplasie de la prostate (), Hémorragie postopératoire (étiologie), Infections urinaires (étiologie), Lasers à solide (effets indésirables), Lasers à solide (usage thérapeutique), Mâle, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Thulium (effets indésirables), Thulium (usage thérapeutique), Études de faisabilité, Études prospectives.
- MESH :
- effets indésirables : Lasers à solide, Thulium.
- usage thérapeutique : Lasers à solide, Thulium.
- étiologie : Hémorragie postopératoire, Infections urinaires.
- Adulte d'âge moyen, Humains, Hyperplasie de la prostate, Mâle, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de faisabilité, Études prospectives.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Feasibility Studies, Humans, Lasers, Solid-State (adverse effects), Lasers, Solid-State (therapeutic use), Male, Middle Aged, Postoperative Hemorrhage (etiology), Prospective Studies, Prostatic Hyperplasia (surgery), Thulium (adverse effects), Thulium (therapeutic use), Treatment Outcome, Urinary Tract Infections (etiology).
- MESH :
- chemical , adverse effects : Thulium.
- adverse effects : Lasers, Solid-State.
- etiology : Postoperative Hemorrhage, Urinary Tract Infections.
- surgery : Prostatic Hyperplasia.
- therapeutic use : Lasers, Solid-State, Thulium.
- Aged, Aged, 80 and over, Feasibility Studies, Humans, Male, Middle Aged, Prospective Studies, Treatment Outcome.
Abstract
Thulium:YAG (Tm:YAG) vaporesection has been introduced and efficiency was shown on smaller prostates. Criticism mainly referred to prolonged operation time in larger prostates, which appears to be a potential limitation compared to HoLEP. Aim of the study was to evaluate feasibility and efficiency of Tm:YAG VapoEnucleation in larger prostates.
DOI: 10.1007/s00345-008-0370-0
PubMed: 19184038
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000545
Links to Exploration step
pubmed:19184038Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.</title>
<author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany. thorsten.bach@uro.ma.uni-heidelberg.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Urology, Asklepios Hospital Barmbek, Hamburg</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wendt Nordahl, G" sort="Wendt Nordahl, G" uniqKey="Wendt Nordahl G" first="G" last="Wendt-Nordahl">G. Wendt-Nordahl</name>
</author>
<author><name sortKey="Michel, M S" sort="Michel, M S" uniqKey="Michel M" first="M S" last="Michel">M S Michel</name>
</author>
<author><name sortKey="Herrmann, T R W" sort="Herrmann, T R W" uniqKey="Herrmann T" first="T R W" last="Herrmann">T R W. Herrmann</name>
</author>
<author><name sortKey="Gross, A J" sort="Gross, A J" uniqKey="Gross A" first="A J" last="Gross">A J Gross</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="doi">10.1007/s00345-008-0370-0</idno>
<idno type="RBID">pubmed:19184038</idno>
<idno type="pmid">19184038</idno>
<idno type="wicri:Area/PubMed/Corpus">000545</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000545</idno>
<idno type="wicri:Area/PubMed/Curation">000545</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000545</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.</title>
<author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany. thorsten.bach@uro.ma.uni-heidelberg.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Urology, Asklepios Hospital Barmbek, Hamburg</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wendt Nordahl, G" sort="Wendt Nordahl, G" uniqKey="Wendt Nordahl G" first="G" last="Wendt-Nordahl">G. Wendt-Nordahl</name>
</author>
<author><name sortKey="Michel, M S" sort="Michel, M S" uniqKey="Michel M" first="M S" last="Michel">M S Michel</name>
</author>
<author><name sortKey="Herrmann, T R W" sort="Herrmann, T R W" uniqKey="Herrmann T" first="T R W" last="Herrmann">T R W. Herrmann</name>
</author>
<author><name sortKey="Gross, A J" sort="Gross, A J" uniqKey="Gross A" first="A J" last="Gross">A J Gross</name>
</author>
</analytic>
<series><title level="j">World journal of urology</title>
<idno type="eISSN">1433-8726</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Feasibility Studies</term>
<term>Humans</term>
<term>Lasers, Solid-State (adverse effects)</term>
<term>Lasers, Solid-State (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Postoperative Hemorrhage (etiology)</term>
<term>Prospective Studies</term>
<term>Prostatic Hyperplasia (surgery)</term>
<term>Thulium (adverse effects)</term>
<term>Thulium (therapeutic use)</term>
<term>Treatment Outcome</term>
<term>Urinary Tract Infections (etiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Humains</term>
<term>Hyperplasie de la prostate ()</term>
<term>Hémorragie postopératoire (étiologie)</term>
<term>Infections urinaires (étiologie)</term>
<term>Lasers à solide (effets indésirables)</term>
<term>Lasers à solide (usage thérapeutique)</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Thulium (effets indésirables)</term>
<term>Thulium (usage thérapeutique)</term>
<term>Études de faisabilité</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Thulium</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lasers, Solid-State</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lasers à solide</term>
<term>Thulium</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Postoperative Hemorrhage</term>
<term>Urinary Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostatic Hyperplasia</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Lasers, Solid-State</term>
<term>Thulium</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Lasers à solide</term>
<term>Thulium</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hémorragie postopératoire</term>
<term>Infections urinaires</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Feasibility Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Humains</term>
<term>Hyperplasie de la prostate</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études de faisabilité</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Thulium:YAG (Tm:YAG) vaporesection has been introduced and efficiency was shown on smaller prostates. Criticism mainly referred to prolonged operation time in larger prostates, which appears to be a potential limitation compared to HoLEP. Aim of the study was to evaluate feasibility and efficiency of Tm:YAG VapoEnucleation in larger prostates.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">19184038</PMID>
<DateCreated><Year>2009</Year>
<Month>08</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2009</Year>
<Month>12</Month>
<Day>31</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8726</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>27</Volume>
<Issue>4</Issue>
<PubDate><Year>2009</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>World journal of urology</Title>
<ISOAbbreviation>World J Urol</ISOAbbreviation>
</Journal>
<ArticleTitle>Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.</ArticleTitle>
<Pagination><MedlinePgn>541-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00345-008-0370-0</ELocationID>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Thulium:YAG (Tm:YAG) vaporesection has been introduced and efficiency was shown on smaller prostates. Criticism mainly referred to prolonged operation time in larger prostates, which appears to be a potential limitation compared to HoLEP. Aim of the study was to evaluate feasibility and efficiency of Tm:YAG VapoEnucleation in larger prostates.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">VapoEnucleation was performed using a 70 W continuous wave-laser. After enucleation tissue was morcellated within the bladder. Prospectively assessed outcomes were improvement in urodynamic parameter and the intra- and postoperative course. Complications were recorded.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 88 consecutive patients with prostatic enlargement underwent VapoEnucleation. Prostatic volume was 61.3 +/- 24.0 cc (30-160). OR-time was 72 min +/- 26.6 (35-144) and laser-time 32.4 +/- 10.1 min (16.3-59.3). Applied laser energy was 123.7 +/- 40.6 kJ (67.8-240.9). An average of 31.7 +/- 18.3 g of tissue was retrieved. Pathology revealed four patients with incidental carcinoma. Foley catheter-time was 2 days and the suprapubic tube, if placed, was removed on the third postoperative day on average. Twelve complications were recorded, including bleeding (3), urinary tract infection (6), second-look procedure, due to insufficient deobstruction (2). Re-catherization after successful initial voiding trial was necessary in one patient. Mean peak flow rate improved from 3.5 +/- 4.7 to 19.8 +/- 11.6 ml/s and post-voiding residual urine decreased from 121.4 +/- 339.9 to 22.4 +/- 32.7 ml.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The functional outcomes demonstrate efficiency of Tm:YAG VapoEnucleation for patients with larger prostates. From our experience, learning curve in VapoEnucleation is short and complications are minimal. Theoretically, no limitation in prostate size occurs. Long-term follow-up is needed to prove durability.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bach</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany. thorsten.bach@uro.ma.uni-heidelberg.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wendt-Nordahl</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Michel</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Herrmann</LastName>
<ForeName>T R W</ForeName>
<Initials>TR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gross</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D023362">Evaluation Studies</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2009</Year>
<Month>01</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>World J Urol</MedlineTA>
<NlmUniqueID>8307716</NlmUniqueID>
<ISSNLinking>0724-4983</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>8RKC5ATI4P</RegistryNumber>
<NameOfSubstance UI="D013932">Thulium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005240">Feasibility Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D053844">Lasers, Solid-State</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D019106">Postoperative Hemorrhage</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013932">Thulium</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014552">Urinary Tract Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year>
<Month>11</Month>
<Day>3</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2008</Year>
<Month>12</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2009</Year>
<Month>1</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1007/s00345-008-0370-0</ArticleId>
<ArticleId IdType="pubmed">19184038</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000545 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000545 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Terre |area= ThuliumV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:19184038 |texte= Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19184038" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ThuliumV1
![]() | This area was generated with Dilib version V0.6.21. | ![]() |